GLR1044 Injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GLR1044 Injection, covering 2026-01-12 to 2026-01-12. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Biosimilarity of GLR1044 Injection and Dupilumab Injection (Dupixent®) in Healthy Adult Male Subjects [Phase 1]